OXEMET 1000 mg coated tablets (metformin hydrochloride)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for OXEMET 1000 mg coated tablets (metformin hydrochloride), covering 2017-12-22 to 2017-12-22. Get the full timeline:
Most recent: Clinical Trial Update: OXEMET™ 1000 mg Coated Tablets (Metformin Hydrochloride) Bioequivalence Study. OXEMET (TM) is a Trademark of the GlaxoSmithKline Group of Companies. GLAFORNIL(TM) is a Trademark of Merck. [Phase 4]